Budget Impact Analisis of Switching From DPT and Monovalent Vaccines to DTaP–IPV-Hib Combined Vaccine Into Russian Immunization Schedule

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction To: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon®): An Updated Review of Its Use in Primary and Booster Vaccination

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2019English

An Insight Into the Immunization Coverage for Combined Vaccines in Albania

European Scientific Journal, ESJ
2017English

Persistence of Antibodies Against Diphtheria, Tetanus, Pertussis, and Poliovirus Types I, II, and III Following Immunization With DTaP Combined With Inactivated Wild-Type Polio Vaccine (DTaP-wIPV)

Japanese Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

From the CDC: DTaP Vaccine Voluntarily Recalled

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

Immunogenicity and Safety of a Combined DTPa-IPV/Hib Vaccine Administered as a Three-Dose Primary Vaccination Course in Healthy Korean Infants: Phase III, Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Potency/Immunogenicity Profile of DPT Vaccines Used in the Expanded Programme on Immunization in South-East, Nigeria

Journal of Vaccines & Vaccination
2014English

Immunogenicity and Safety of a Fully Liquid DTaP-IPV-Hep B-PRP-T Vaccine at 2-4-6 Months of Age in Peru

Journal of Vaccines & Vaccination
2012English

Clinical and Epidemiological Impact of Varicella Infection in Children Prior to the Introduction of the Varicella Vaccine in the National Immunization Schedule of Argentina

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2019English

A Second Dose of a Measles-Mumps-Rubella Vaccine Administered to Healthy Four-To-Six-Year-Old Children: A Phase III, Observer-Blind, Randomized, Safety and Immunogenicity Study Comparing GSK MMR and MMR II With and Without DTaP-IPV and Varicella Vaccines Co-Administration

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy